Renegade Bio is a medical diagnostics, SOSV backed, IndieBio startup. The company is a B Corporation, with the highest standards of social and environmental performance, public transparency and legal accountability.
Renegade Bio improved on the CDC PCR-based diagnostic testing method for COVID-19 by reducing four reactions to a single step that eliminates the need for the RNA extraction step. The test is claimed to cost 70% less and take half the time to complete. Renegade partnered with the Bay Area Phlebotomy and Laboratory Services with the aim to allow open public testing on-demand as an Uber-like service. The company is beginning by testing San Francisco Bay Area first responders and police forces and is running 1300 tests every three days.
Timeline
Funding rounds
People
Craig Rouskey
CSO, Co-Founder
Gabriel Paulino
CEO, Co-Founder
Julia Russotti
CFO